In a cerulein-induced AP model, decreased ROS production, subsequent reduction in NLRP3 activation and limited pancreatic damage were observed after administration of INT-777, making a protective use for this agent in patients with AP a possibility [119]. This evidence concerns the gene NLRP3 and alkaline phosphatase measurement.